Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials

被引：0
|
作者：
Daniel Binder
Ralf-Harto Hübner
Bettina Temmesfeld-Wollbrück
Peter Schlattmann
机构：
[1] Charité-Universitätsmedizin Berlin,Department of Internal Medicine/Infectious and Respiratory Diseases
[2] Informatics and Documentation (PS),Department of Medical Statistics
[3] University Hospital of Friedrich-Schiller University Jena,undefined
[4] Medizinische Klinik m. S. Infektiologie und Pneumologie,undefined
[5] Charité-Universitätsmedizin Berlin,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Neoplasms; Drug toxicity; Lung injury; Docetaxel; Gemcitabine; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1575 / 1583
页数：8
相关论文
共 50 条
  • [1] Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials
    Binder, Daniel
    Huebner, Ralf-Harto
    Temmesfeld-Wollbruck, Bettina
    Schlattmann, Peter
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1575 - 1583
  • [2] Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
    Belfiglio, Maurizio
    Fanizza, Caterina
    Tinari, Nicola
    Ficorella, Corrado
    Iacobelli, Stefano
    Natoli, Clara
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (02) : 221 - 229
  • [3] Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
    Maurizio Belfiglio
    Caterina Fanizza
    Nicola Tinari
    Corrado Ficorella
    Stefano Iacobelli
    Clara Natoli
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 221 - 229
  • [4] A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer
    Yan, Longxiang
    Lu, Wenming
    Huang, Wenjin
    Zoa, Alexis Bindzi
    Zheng, Jiang
    Qin, Mingbai
    Du, Jing
    Xiao, Qiuxiang
    Liu, Zhiping
    Tian, Yuantong
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (05) : 66
  • [5] Meta-analysis of gemcitabine and cisplatin combination chemotherapy versus gemcitabine alone for pancreatic cancer
    Huang, Diyu
    Fang, Jie
    Luo, Gaojian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 104 - 108
  • [6] The comparisons of the efficacy and toxicity between gefitinib and docetaxel for patients with advanced nonsmall-cell lung cancer: A meta-analysis from randomized controlled clinical trials
    Zhao, Y. L.
    Han, S.
    Pu, R.
    Shi, L. W.
    INDIAN JOURNAL OF CANCER, 2014, 51 (07) : 86 - 91
  • [7] Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel
    Veltkamp, Stephan A.
    Terwogt, Jetske M. Meerum
    van den Heuvel, Michel M.
    van Boven, Hester H.
    Schellens, Jan H. M.
    Rodenhuis, Sjoerd
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (03) : 279 - 281
  • [8] Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel
    Stephan A. Veltkamp
    Jetske M. Meerum Terwogt
    Michel M. van den Heuvel
    Hester H. van Boven
    Jan H. M. Schellens
    Sjoerd Rodenhuis
    Investigational New Drugs, 2007, 25 : 279 - 281
  • [9] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Shui-Fang Jin
    Zhao-Kun Fan
    Lei Pan
    Li-Ming Jin
    Hepatobiliary & Pancreatic Diseases International, 2017, 16 (03) : 236 - 244
  • [10] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Jin, Shui-Fang
    Fan, Zhao-Kun
    Pan, Lei
    Jin, Li-Ming
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (03) : 236 - 244
12345